HomeInsightsPE

Gufic Biosciences Ltd PE Ratio

Gufic Biosciences Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Dec 13, 2024)

stocks purchased

2.7 K

Stocks Traded

(Dec 13, 2024)

Last Updated on: Dec 14, 2024

Image

Gufic BioSciences Ltd

NSE: GUFICBIO

PE

51

Last updated on: Dec 14, 2024

Key Highlights

  • The P/E Ratio of Gufic BioSciences Ltd is 51 as of 14 Dec 15:30 PM .
  • The P/E Ratio of Gufic BioSciences Ltd is 33 as of March 2024 .
  • The Latest Trading Price of Gufic BioSciences Ltd is ₹ 432.15 as of 13 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.
Image

Gufic BioSciences Ltd

NSE: GUFICBIO

PE

33

Last updated on: Invalid Date

Company Fundamentals for Gufic BioSciences Ltd

No data available

Image

Gufic BioSciences Ltd

NSE: GUFICBIO

Share Price

₹ 432.15

-4.50 (-1.03%)

stock direction

Last updated on: Dec 13, 2024

Market Price of Gufic BioSciences Ltd

1M

1Y

3Y

5Y

Monitoring Gufic BioSciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Dec 2024432.15
12 Dec 2024436.65
11 Dec 2024445.4
10 Dec 2024441.25
09 Dec 2024436.15
06 Dec 2024445.5
05 Dec 2024446.5
04 Dec 2024444.55
03 Dec 2024446.7
02 Dec 2024411.05

SWOT Analysis Of Gufic BioSciences Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Gufic BioSciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Gufic BioSciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Gufic BioSciences Ltd514,333
Sun Pharmaceuticals Industries Ltd384,35,179
Divis Laboratories Ltd851,55,995
Cipla Ltd251,16,890
Torrent Pharmaceuticals Ltd651,13,295
Mankind Pharma Ltd501,05,787

Key Valuation Metric of Gufic BioSciences Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Gufic BioSciences Ltd

No data available

* All values are in crore

Historical Revenue of Gufic BioSciences Ltd

No data available

* All values are in crore

Historical EBITDA of Gufic BioSciences Ltd

No data available

* All values are in crore

Historical Net Profit of Gufic BioSciences Ltd

No data available

* All values are in crore

Historical Dividend Payout of Gufic BioSciences Ltd

No data available

* All values are in %

About Gufic BioSciences Ltd

  • Gufic Biosciences (GBL) was incorporated in Jul'84.
  • The Company is a result of a reverse merger of itself with Central Finance.
  • The promoters of GBL took over Central Finance at Rs 40-42 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a long-standing presence in the pharma industry.
  • In 1960, the family set up a joint venture company called Lyka Labs.
  • In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born.

Gufic BioSciences Ltd News Hub

News

Gufic BioSciences standalone net profit rises 1.16% in the June 2024 quarter

Net profit of Gufic BioSciences rose 1.16% to Rs 20.86 crore in the quarter ended June 202...

Read more

2024-08-14 00:00:00

News

Gufic BioSciences to hold board meeting

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 14 Augus...

Read more

2024-08-12 00:00:00

News

Gufic BioSciences AGM scheduled

Gufic BioSciences announced that the Annual General Meeting (AGM) of the company will be h...

Read more

2024-09-05 00:00:00

News

Gufic BioSciences to discuss results

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 14 Novem...

Read more

2024-11-09 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Gufic BioSciences Ltd

What is the current PE Ratio of Gufic BioSciences Ltd?

The Current PE Ratio of Gufic BioSciences Ltd is 51.02 as on 14 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 14 Dec 2024.

What was the PE Ratio of Gufic BioSciences Ltd last year?

The PE Ratio of Gufic BioSciences Ltd was 0.0 last year, now the PE ratio is 51.02, showing a year-on-year growth of -%.

What does the PE Ratio of Gufic BioSciences Ltd indicate about its stock?

The PE Ratio of Gufic BioSciences Ltd is 51.02. This ratio indicates that investors are willing to pay 51.02 times the earnings per share for each share of Gufic BioSciences Ltd.

What is the PE Ratio Growth of Gufic BioSciences Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Gufic BioSciences Ltd grew by -% whereas, the EPS ratio grew by 4.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions